EcoDrugPlus

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion A

Ensembl ID : ENSOKIG00005033439
Gene Symbol: FAUA
1 Cross references
295 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSOKIG00005024469
Gene Symbol: GPR119
1 Cross references
174 Possible Orthologues:

G1/s-Specific Cyclin-D1

Ensembl ID : ENSOKIG00005011664
Gene Symbol: LOC109885836
3 Cross references
228 Possible Orthologues:

Gtpase Kras

Ensembl ID : ENSOKIG00005005761
Gene Symbol: LOC109867582
3 Cross references
202 Possible Orthologues:

Gtpase Kras

Ensembl ID : ENSOKIG00005043614
Gene Symbol: LOC109867582
3 Cross references
201 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSOKIG00005037504
Gene Symbol: HCK
1 Cross references
196 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSOKIG00005029059
Gene Symbol: ITK
3 Cross references
202 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSOKIG00005005498
Gene Symbol: IMPDH2
1 Cross references
194 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSOKIG00005046327
Gene Symbol: JAK1
1 Cross references
204 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSOKIG00005015807
Gene Symbol: JAK1
3 Cross references
158 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSOKIG00005033402
Gene Symbol: JAK1
3 Cross references
159 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSOKIG00005035557
Gene Symbol: JAK2A
1 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).